Development and validation method for quantitative determination of rifampicin in human plasma and its application in bioequivalence test
- In: Poster presentation
- At: Seoul (South Korea) (2017)
- Type: Poster
- Poster code: POS-PAA-011
- By: LUKITANINGSIH, Endang (Gadjah Mada University, Pharmaceutical Chemistry Department, Yogyakarta, Indonesia)
- Co-author(s): Endang Lukitaningsih:
Fathul Jannah: Advanced Pharmaceutical Sciences lab, Gadjah Mada University, Yogyakarta, Indonesia
Arief Rahman Hakim: Pharmacology and Clinical Pharmacy, Gadjah Mada University, Yogyakarta, Indonesia
Ratna Dewi Puspita: Gadjah Mada University Hospital, Gadjah Mada University, Yogyakarta, Indonesia
Zullies Ikawati: Pharmacology and Clinical Pharmacy, Gadjah Mada University, Yogyakarta, Indonesia
BackgroundRifampicin has been used worldwide as first line drug-prescribed throughout tuberculosis therapy
PurposeThis study aims to develop and to validate an HPLC method couple with a UV detection for determination of rifampicin for bioequivalence study.
MethodsThe chromatographic separation was achieved on a RP-C18 column (LachromHitachi, 250 x.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019